Sativex for MS Spasticity | Nabiximols Spray

£375.00

Sativex for MS spasticity – prescription Sativex for MS spasticity spray with THC and CBD that helps relieve moderate to severe muscle stiffness in adults with multiple sclerosis when other treatments are insufficient.

Category: Oral Sprays

Tags: cannabis-based medicine, GW Pharmaceuticals, Jazz Pharmaceuticals, MS spasticity, multiple sclerosis spray, muscle stiffness relief, nabiximols, oromucosal spray, Sativex, THC CBD spray

Description
Reviews (0)

Description

Sativex for MS Spasticity | Nabiximols Spray – Sativex for MS spasticity

Sativex for MS spasticity is a prescription oromucosal spray containing nabiximols, Sativex for MS spasticity a balanced extract of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) from Cannabis sativa. Each 100-microlitre spray delivers 2.7 mg THC and 2.5 mg CBD. It is indicated as add-on therapy for adult patients with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other

Sativex for MS spasticity and who show clinically significant improvement during an initial trial. Developed by Sativex for MS spasticity (now part of Jazz Pharmaceuticals), Sativex for MS spasticity is applied under the tongue or inside the cheek and titrated carefully under specialist supervision, typically up to a maximum of 12 sprays daily. Sativex for MS spasticity helps reduce muscle stiffness and spasms, improving daily function and quality of life for eligible patients when conventional treatments fall short. Always use under medical guidance.

Sativex for MS spasticity